Sign in
4

Changes in Ownership

MBX Biosciences, Inc. Filed Acc 0001193125-26-082562

President & CEO acquired 28,768 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hawryluk P. Kent · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-26 Exercise or conversion : show line 1 in the form +28,768 $16.00 $460,288 728,274 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-26 Exercise or conversion : show line 2 in the form Stock option (right to buy) −28,768 91,668 D
Loading xslF345X05/ownership.xml…